Safety, Monitoring, and Eligibility Criteria GLP-1 and GIP receptor agonists are contraindicated in personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe pancreatitis, and uncontrolled diabetes
PEPITEM-derived tripeptides showed results in as little as 7 days in preclinical studies
This hormone communicates with the hypothalamus, the brains appetite control centre, to reduce hunger and food-seeking behaviour
The adverse effects associated with tirzepatide use in patients at increased risk of cardiovascular events: a systematic review with meta-analysis and Trial Sequential Analysis
The broadest human evidence base of the three, a physiological nighttime pulse, preserved feedback [PMID 8329825, 9141536]
DPP-4 inhibitors included Merck's Januvia and AstraZeneca's Onglyza